Lactose (India) Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 469912, "name": "Lactose (India)", "stock_name": "Lactose (India)", "full_name": "Lactose (India) Ltd", "name_url": "stocks-analysis/lactose-india", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "100.80", "chg": -0.65, "chgp": "-0.64%", "dir": -1, "prev_price": "101.45", "mcapval": "128.00 Cr", "mcap": "Micro Cap", "scripcode": 524202, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE058I01013", "curr_date": "Sep 21, 03:30 PM", "curr_time": "21:54 PM", "last_traded_at": "Sep 21, 03:30 PM IST", "bse_nse_vol": "4.56 k", "exc_status": "Active", "traded_date": "Sep 21, 2026", "traded_date_str": "2026 09 21", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lactose-india-469912-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Lactose (India) Ltd Downgraded to Sell Amid Mixed Financials and Market Pressure", "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-ltd-downgraded-to-sell-amid-mixed-financials-and-market-pressure-4194135", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LactoseIndiaLtd_mojoScore_4194135.png", "date": "2026-09-16 08:05:21", "description": "Lactose (India) Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 15 Sep 2026, reflecting a reassessment of its valuation, financial trends, quality metrics, and technical outlook. Despite robust revenue growth and improving profitability, concerns over promoter share pledging and underperformance relative to the broader market have weighed heavily on investor sentiment, prompting a cautious stance on this pharmaceuticals and biotechnology micro-cap." }, { "title": "Lactose (India) Ltd Upgraded to Hold on Improved Valuation and Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-ltd-upgraded-to-hold-on-improved-valuation-and-technicals-4185607", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LactoseIndiaLtd_mojoScore_4185607.png", "date": "2026-09-08 08:04:15", "description": "Lactose (India) Ltd has seen its investment rating upgraded from Sell to Hold as of 07 Sep 2026, reflecting a notable improvement in valuation metrics and technical indicators. Despite recent underperformance relative to the broader market, the company’s financial trends and quality parameters support a more balanced outlook for investors." }, { "title": "Lactose (India) Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4180182", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LactoseIndiaLtd_valuationdot_4180182.png", "date": "2026-09-03 08:00:41", "description": "Lactose (India) Ltd has seen a marked shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects a significant reappraisal of its price-to-earnings and price-to-book ratios relative to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lactose (India) Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-ltd-is-rated-sell-by-marketsmojo-4177616", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LactoseIndiaLtd_mojoScore_4177616.png", "date": "2026-09-01 10:11:23", "description": "Lactose (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Lactose (India) Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4168165", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LactoseIndiaLtd_valuationdot_4168165.png", "date": "2026-08-25 08:00:40", "description": "Lactose (India) Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the evolving price-to-earnings (P/E) and price-to-book value (P/BV) ratios in comparison to its historical averages and peer group, providing investors with a comprehensive view of the stock’s current price attractiveness within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lactose (India) Ltd Falls 6.93%: Downgrade and Valuation Shifts Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-falls-693-downgrade-and-valuation-shifts-shape-the-week-4165608", "imagepath": "", "date": "2026-08-22 17:07:21", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>17 Aug:</strong> Stock opens at ₹101.15, down 5.86% amid technical weakness</p>\n <p><strong>18 Aug:</strong> Downgrade to Sell rating announced due to promoter pledge and technical concerns</p>\n <p><strong>19 Aug:</strong> Valuation metrics improve, signalling very attractive price levels</p>\n <p><strong>21 Aug:</strong> Week closes at ₹100.00, down 1.48% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.107.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">..." }, { "title": "Lactose (India) Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/lactose-india-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-4160244", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LactoseIndiaLtd_valuationdot_4160244.png", "date": "2026-08-19 08:00:22", "description": "Lactose (India) Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects a compelling reappraisal of the stock’s price metrics relative to its historical averages and peer group, offering investors a nuanced perspective on its current market standing within the Pharmaceuticals & Biotechnology sector." }, { "title": "Lactose (India) Ltd Downgraded to Sell Amid Technical Weakness and Promoter Pledge Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-ltd-downgraded-to-sell-amid-technical-weakness-and-promoter-pledge-concerns-4158796", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LactoseIndiaLtd_mojoScore_4158796.png", "date": "2026-08-18 08:04:47", "description": "Lactose (India) Ltd has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite robust quarterly financials and healthy long-term sales growth, bearish technical signals and significant promoter share pledging have raised caution among investors, prompting a reassessment of the stock’s outlook." }, { "title": "Lactose (India) Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen", "link": "https://www.marketsmojo.com/news/stock-recommendation/lactose-india-ltd-upgraded-to-hold-as-technicals-improve-and-financials-strengthen-4149327", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LactoseIndiaLtd_mojoScore_4149327.png", "date": "2026-08-12 08:04:01", "description": "Lactose (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality assessment. This upgrade comes amid strong quarterly financial performance and a shift in market sentiment, positioning the micro-cap pharmaceutical company for cautious optimism among investors." } ], "total": 216, "sid": "469912", "stock_news_url": "https://www.marketsmojo.com/news/lactose-india-469912" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "08-Sep-2026", "details": "Pursuant to the Regulation 30 and 47(3) of SEBI (LODR) Regulations2015 we hereby submit the newspaper publication for intimation of upcoming AGM.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-Sep-2026", "details": "Pursuant to Regulation 30 and 47(3) of SEBI (LODR) Regulations2015 we hereby submit the newspaper publication for Pre-dispatch of Annual Report along the Notice of the upcoming AGM.", "source": "BSE" }, { "caption": "Shareholders Meeting - AGM On Wednesday 30Th September 2026", "datetime": "07-Sep-2026", "details": "Pursuant to the provisions of SEBI (LODR) Regulation 2015 We hereby submit the intimation towards Annual General Meeting of the Company scheduled to be held on Wednesday 30th September 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

17 Aug: Stock opens at ₹101.15, down 5.86% amid technical weakness

18 Aug: Downgrade to Sell rating announced due to promoter pledge and technical concerns

19 Aug: Valuation metrics improve, signalling very attractive price levels

21 Aug: Week closes at ₹100.00, down 1.48% on the day

Week Open

Rs.107.45

...

Read full news article

Lactose (India) Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-08-19 08:00:22

Lactose (India) Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to a very attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects a compelling reappraisal of the stock’s price metrics relative to its historical averages and peer group, offering investors a nuanced perspective on its current market standing within the Pharmaceuticals & Biotechnology sector.

Read full news article

Lactose (India) Ltd Downgraded to Sell Amid Technical Weakness and Promoter Pledge Concerns

2026-08-18 08:04:47

Lactose (India) Ltd has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite robust quarterly financials and healthy long-term sales growth, bearish technical signals and significant promoter share pledging have raised caution among investors, prompting a reassessment of the stock’s outlook.

Read full news article

Lactose (India) Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen

2026-08-12 08:04:01

Lactose (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality assessment. This upgrade comes amid strong quarterly financial performance and a shift in market sentiment, positioning the micro-cap pharmaceutical company for cautious optimism among investors.

Read full news article